Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Trial Concerning Gene Expression Profiling to Predict the Chemosensitivity of Invasive Bladder Cancer

NCT00516750 is registered in ClinicalTrials.gov with Kyoto University as lead sponsor.

NCT NCT00516750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00516750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Trial Concerning Gene Expression Profiling to Predict the Chemosensitivity of Invasive Bladder Cancer
Lead sponsor
Kyoto University
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2007
Completion date
February 28, 2009
Enrollment
100 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer